OCRL Antikörper (AA 146-240)
-
- Target Alle OCRL Antikörper anzeigen
- OCRL (Oculocerebrorenal Syndrome of Lowe (OCRL))
-
Bindungsspezifität
- AA 146-240
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser OCRL Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Enzyme Immunoassay (EIA)
- Spezifität
- This antibody reacts to OCRL.
- Aufreinigung
- Affinity chromatography on Protein A
- Immunogen
- OCRL antibody was raised against oCRL (NP_000267, 146 a.a. ~ 240 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
- Klon
- 4A6
- Isotyp
- IgG2a
- Top Product
- Discover our top product OCRL Primärantikörper
-
anti-Oculocerebrorenal Syndrome of Lowe (OCRL) (AA 146-239) antibody
OCRL Reaktivität: Human WB, ELISA, IHC (p), RNAi Wirt: Maus Monoclonal 4A6 unconjugated
anti-Oculocerebrorenal Syndrome of Lowe (OCRL) (C-Term) antibodyOCRL Reaktivität: Human WB, IHC (p), ICC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Oculocerebrorenal Syndrome of Lowe (OCRL) (AA 121-271) antibodyOCRL Reaktivität: Human ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Oculocerebrorenal Syndrome of Lowe (OCRL) (AA 146-240) antibodyOCRL Reaktivität: Human WB, ELISA, IHC, IHC (p) Wirt: Maus Monoclonal 4A6 unconjugated
anti-Oculocerebrorenal Syndrome of Lowe (OCRL) (Internal Region) antibodyOCRL Reaktivität: Human, Maus WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Oculocerebrorenal Syndrome of Lowe (OCRL) antibodyOCRL Reaktivität: Human, Maus, Ratte WB Wirt: Kaninchen Polyclonal unconjugated
anti-Oculocerebrorenal Syndrome of Lowe (OCRL) (AA 1-893) antibodyOCRL Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Oculocerebrorenal Syndrome of Lowe (OCRL) (AA 1-893) antibodyOCRL Reaktivität: Human WB Wirt: Maus Polyclonal unconjugated
anti-Oculocerebrorenal Syndrome of Lowe (OCRL) (C-Term) antibodyOCRL Reaktivität: Human, Maus WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- 1,0 mg/mL
- Buffer
- PBS, pH 7.2
- Handhabung
- Avoid repeated freezing and thawing.
- Lagerung
- -20 °C
-
- Target
- OCRL (Oculocerebrorenal Syndrome of Lowe (OCRL))
- Andere Bezeichnung
- OCRL (OCRL Produkte)
- Synonyme
- OCRL antikoerper, wu:fi09g03 antikoerper, zgc:152864 antikoerper, locr antikoerper, nphl2 antikoerper, ocrl1 antikoerper, inpp5f antikoerper, INPP5F antikoerper, LOCR antikoerper, NPHL2 antikoerper, OCRL-1 antikoerper, OCRL1 antikoerper, 9530014D17Rik antikoerper, BB143339 antikoerper, OCRL, inositol polyphosphate-5-phosphatase antikoerper, phosphatidylinositol polyphosphate 5-phosphatase antikoerper, oculocerebrorenal syndrome of Lowe antikoerper, Ocrl antikoerper, NAEGRDRAFT_58601 antikoerper, OCRL antikoerper, ocrl antikoerper
- Hintergrund
- RelevanceConverts phosphatidylinositol 4,5-bisphosphate to phosphatidylinositol 4-phosphate. Also converts inositol 1,4,5-trisphosphate to inositol 1,4-bisphosphate and inositol 1,3,4,5-tetrakisphosphate to inositol 1,3,4-trisphosphate. May function in lysosomal membrane trafficking by regulating the specific pool of phosphatidylinositol 4,5-bisphosphate that is associated with lysosomes.Synonyms: INPP5F, Inositol polyphosphate 5-phosphatase OCRL-1, Lowe oculocerebrorenal syndrome protein, OCRL-1, OCRL1
- Gen-ID
- 4952
- NCBI Accession
- NP_000267
- UniProt
- Q01968
- Pathways
- Inositol Metabolic Process
-
